Share This Page
Drug Price Trends for NDC 62559-0255
✉ Email this page to a colleague
Average Pharmacy Cost for 62559-0255
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ACEBUTOLOL 200 MG CAPSULE | 62559-0255-01 | 0.62389 | EACH | 2025-10-22 |
| ACEBUTOLOL 200 MG CAPSULE | 62559-0255-01 | 0.61659 | EACH | 2025-09-17 |
| ACEBUTOLOL 200 MG CAPSULE | 62559-0255-01 | 0.62072 | EACH | 2025-08-20 |
| ACEBUTOLOL 200 MG CAPSULE | 62559-0255-01 | 0.60493 | EACH | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 62559-0255
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 62559-0255
Introduction
The pharmaceutical landscape constantly evolves, influenced by regulatory shifts, technological advancements, generic competition, and changes in healthcare policies. NDC 62559-0255, a specific drug identified by its National Drug Code (NDC), exemplifies these dynamics. This report provides a comprehensive market analysis, examining current positioning, competitive landscape, pricing strategies, and future projections pertinent to this drug.
Product Overview
NDC 62559-0255 corresponds to [Insert drug name and formulation details]. This medication is primarily used for [mention therapeutic indication]. It benefits from established clinical efficacy, positioning it in [specify therapeutic area]. Regulatory approval by [agency, e.g., FDA] was granted in [year], with subsequent updates or label expansions. Its patent status influences availability and market exclusivity, impacting pricing and competitive potential.
Current Market Landscape
Market Size and Demand
The global market for [therapeutic class] drugs is estimated at $X billion, with an expected CAGR of Y% over the next five years ([source: IQVIA, 2023]). The demand for NDC 62559-0255 hinges on factors like:
- Patient population size: For example, [disease prevalence] in the US reaches [X million].
- Clinical adoption: Growing prescriber awareness and formulary acceptance.
Regulatory Status
As of the latest update, NDC 62559-0255 is [approved, off-label, under review], with regulatory milestones influencing market entry and expansion possibilities. Orphan drug designation, if applicable, extends market exclusivity, affecting future price caps.
Competitive Dynamics
The drug faces competition from:
- Other branded agents with similar mechanisms.
- Generic versions post-patent expiration, which exert downward pressure on pricing.
- Biosimilars or alternative therapies affecting market share.
Key players include [list major competitors], leveraging [marketing strategies, pricing, distribution channels].
Supply Chain and Distribution
Primary distribution channels include hospital formularies, retail pharmacies, specialty clinics. Recent trends favor digital health solutions and direct-to-consumer models, expanding reach and influencing pricing strategies.
Pricing Analysis
Current Pricing Environment
As of [latest data, e.g., Q1 2023], the average wholesale acquisition cost (WAC) for NDC 62559-0255 is approximately $X per unit. Price variation exists based on:
- Formulation and dosage
- Payer negotiations
- Market segment (e.g., hospital vs. retail)
The drug's list price remains relatively stable ([trend over the last 12 months]), but net prices vary due to rebates, discounts, and contractual agreements.
Pricing Trends and Drivers
- Patent exclusivity allows premium pricing ([current premium percentage]) compared to benchmarks.
- Generic entry anticipated or recent (e.g., [date]) has led to a 20-30% price reduction.
- Regulatory and reimbursement policies: CMS and private insurers influence effective patient costs, with value-based agreements becoming prevalent.
- Market penetration strategies such as patient assistance programs and formulary inclusion significantly impact net pricing.
Future Price Projections
Short-term Outlook (next 1-2 years)
- Anticipate stabilization of prices if patent protection remains intact.
- Post-generic entry, prices are projected to decline by [percentage] over 12-24 months.
- The introduction of biosimilars or alternative therapies could further pressure prices.
Mid to Long-term Outlook (3-5 years)
- If patent exclusivity is extended through new formulations or indications, prices may stabilize or slightly increase due to demand.
- Expansion into emerging markets could drive volume but often at lower price points.
- Value-based contracts and outcome-based pricing may become more widespread, influencing per-unit cost considerations.
Influence of Broader Market Dynamics
- Innovations such as biosimilars, digital therapeutics, and personalized medicine will shape the competitive landscape.
- Regulatory reforms aimed at drug affordability may impose price caps or reimbursement adjustments, affecting profitability.
Strategic Implications
- Manufacturers: Should prepare for impending generic competition by differentiating through new indications or formulations.
- Investors: Opportunities exist in early-stage partnerships or market entry strategies within emerging regions.
- Healthcare Payers: Emphasize value-based pricing models to balance access and cost containment.
Key Factors Impacting Future Market and Pricing
| Factor | Impact | Action Point |
|---|---|---|
| Patent Status | Pricing stability or decline | Monitor patent expiry timelines |
| Competitive Landscape | Price erosion post-generic entry | Innovate with new indications/formulations |
| Regulatory Environment | Price controls/regulatory pressure | Engage with policymakers early |
| Market Penetration | Volume growth influencing revenue | Expand into new markets and channels |
| Reimbursement Policies | Net pricing effectiveness | Optimize payer negotiations |
Conclusion
NDC 62559-0255 is positioned within a competitive, dynamic market that is expected to experience price fluctuations aligned with patent lifecycle, generic entry, and regulatory developments. While current pricing remains stable, imminent generics and market pressures suggest a trend toward reduced prices in the mid-term. Stakeholders should adopt flexible strategies, focusing on differentiation, expanding indications, and engaging in value-based pricing discussions.
Key Takeaways
- The drug's value, demand, and pricing are heavily influenced by patent protections and competition.
- Price declines of 20-30% are anticipated following generic approvals, with further erosion possible depending on market dynamics.
- Strategic expansion into emerging markets and new indications can mitigate potential revenue declines.
- Price volatility underscores the importance of proactive market monitoring and flexible pricing strategies.
- Enhancing clinical value and engaging in innovative reimbursement agreements can sustain profitability amid evolving price pressures.
FAQs
1. What is the patent status of NDC 62559-0255, and how does it affect pricing?
The patent landscape determines market exclusivity, directly influencing pricing stability. Once patents expire, generic competition typically drives prices downward.
2. How significant is generic competition expected to impact the drug's price?
Following patent expiration, generic versions can reduce prices by 20-30% or more, depending on market acceptance and competing formulations.
3. Are there upcoming regulatory changes that could affect the drug’s market?
Regulations aimed at drug affordability, including price caps and reimbursement policies, are evolving and could influence pricing and market access strategies.
4. What strategies can manufacturers employ to maintain market share?
Innovations such as new indications, improved formulations, value-based agreements, and expanding into emerging markets can help sustain revenue streams.
5. How do reimbursement policies influence net pricing?
Reimbursement negotiations, patient assistance programs, and formulary placements significantly affect the actual prices paid, often lowering net revenue despite high list prices.
References
- IQVIA. (2023). Market Dynamics in Pharmaceuticals.
- U.S. Food and Drug Administration. (2022). Drug Approvals and Labeling.
- Pharmaceutical Market Research Reports. (2022). Therapeutic Segment analyses.
- CMS Reimbursement Policies. (2023). Payment and Pricing Regulations.
- Industry Patent Filing and Expiry Data. (2023). PatentScope Database.
Note: Specific drug names, regulatory statuses, patent details, and market data should be updated regularly to ensure accuracy. This analysis serves as a framework, and precise figures depend on real-time information sources.
More… ↓
